Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capitor is an international boutique investment and advisory group focused on financial and investment services, with a strong emphasis on helping clients relocate, invest, and manage assets in South Africa. The firm provides services spanning wealth and asset management, tax and legal advisory, insurance, lending, foreign exchange, and related consulting. Although Capitor has participated in healthcare-related transactions, including a landmark deal involving GE Healthcare’s U.S. nuclear medicine pharmacy network, Capitor itself is not a biotech, pharma, or healthcare operating company. It appears to function primarily as an investment and advisory business rather than a developer of therapeutics, diagnostics, or medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Capitor.